(Q40762695)

23 September 2017

title

Delivery of diagnostic agents in computed tomography (English)

1 reference

23 September 2017

Krause W

1

1 reference

23 September 2017

language of work or name

English

0 references

publication date

1 April 1999

1 reference

Advanced Drug Delivery Reviews

23 September 2017

published in

1 reference

23 September 2017

volume

37

1 reference

23 September 2017

issue

1-3

1 reference

23 September 2017

page(s)

159-173

1 reference

ROENTGENOGRAPHY OF URINARY TRACT DURING EXCRETION OF SODIUM IODID

23 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2898%2900105-7

7 January 2021

[CT contrast administration of iodine, gadolinium and ytterbium. In-vitro studies and animal experiments]

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2898%2900105-7

7 January 2021

Presence and removal of arteriovenous malformation: Impact of regional cerebral blood flow, as assessed with xenon/CT.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2898%2900105-7

7 January 2021

Application of pharmacokinetics to computed tomography: injection rates and schemes: mono-, bi-, or multiphasic?

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2898%2900105-7

7 January 2021

In vitro and animal experiments in contrast media testing

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2898%2900105-7

7 January 2021

Pharmacokinetics and plasma albumen binding of iotroxic acid (Biliscopin), iodoxic acid (Endomirabil) and ioglycamine (Biligram) (author's transl)

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2898%2900105-7

7 January 2021

CT of experimental hepatoma using the hepatocyte-specific lipid emulsion fp 736-03

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2898%2900105-7

7 January 2021

CT with the hepatocyte-specific contrast medium fp 736-04 in an experimental model of liver steatosis

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2898%2900105-7

7 January 2021

Experimental Investigation of a New Iodinated Lipid Emulsion for Computed Tomography of the Liver

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2898%2900105-7

7 January 2021

Physicochemical characterization of a synthetic lipid emulsion for hepatocyte-selective delivery of lipophilic compounds: application to polyiodinated triglycerides as contrast agents for computed tomography

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2898%2900105-7

7 January 2021

CT depiction of experimental liver tumors: contrast enhancement with hepatocyte-selective iodinated triglyceride versus conventional techniques

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2898%2900105-7

7 January 2021

Ytterbium- and dysprosium-EOB-DTPA. A new prototype of liver-specific contrast agents for computed tomography.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2898%2900105-7

7 January 2021

Hepatic kinetics and magnetic resonance imaging of gadolinium ethoxybenzyl diethylenetriaminepentacetic acid (Gd-EOB-DTPA) in dogs

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2898%2900105-7

7 January 2021

Preclinical evaluation of Gd-EOB-DTPA as a contrast agent in MR imaging of the hepatobiliary system

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2898%2900105-7

7 January 2021

A prototype liver-specific contrast medium for CT: preclinical evaluation of gadoxetic acid disodium, or Gd-EOB-DTPA

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2898%2900105-7

7 January 2021

Detection of focal liver lesions: CT of the hepatobiliary system with gadoxetic acid disodium, or Gd-EOB-DTPA.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2898%2900105-7

7 January 2021

Thorotrast and the liver--revisited

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2898%2900105-7

7 January 2021

Lung carcinoma and malignant mesothelioma in patients exposed to Thorotrast: incidence, histology and p53 status.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2898%2900105-7

7 January 2021

Liver enhancement techniques in computed tomography. A comparison of intravenous bolus, computed tomographic portography, and iodipamide ethyl ester particle injections in a canine model

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2898%2900105-7

7 January 2021

Biodistribution of a particulate hepatolienographic CT contrast agent: a study of iodipamide ethyl ester in the rat

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2898%2900105-7

7 January 2021

Uptake and dissolution of particulate iodipamide ethyl ester in the spleen. A morphologic study

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2898%2900105-7

7 January 2021

Development of biodegradable ioxilan carbonate particles for contrast enhancement of the liver in computed tomography scanning: toxicity assessment

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2898%2900105-7

7 January 2021

Biodistribution of cyclic carbonate of ioxilan: a radiopaque particulate macrophage imaging agent

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2898%2900105-7

7 January 2021

Preparation, characterization, and evaluation of ioxilan carbonate particles for computed tomography contrast enhancement of liver.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2898%2900105-7

7 January 2021

Intrahepatic metastatic nodules of hepatocellular carcinoma detected at lipiodol-CT: imaging-pathologic correlation

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2898%2900105-7

7 January 2021

Small Hepatocellular Carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2898%2900105-7

7 January 2021

Persistence of lipiodol for 13 months in metastatic deposits in the liver on computed tomography

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2898%2900105-7

7 January 2021

Experimental Comparison of EOE-13 and Perfluoroctylbromide for the CT Detection of Hepatic Metastases

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2898%2900105-7

7 January 2021

Perfluoroctylbromide: a reticuloendothelial-specific and tumor-imaging agent for computed tomography

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2898%2900105-7

7 January 2021

Delineation of the spleen by a combination of proliposomes with water-soluble contrast media: an experimental study using computed tomography

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2898%2900105-7

7 January 2021

Characterization of liposomes containing iodine-125-labeled radiographic contrast agents

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2898%2900105-7

7 January 2021

Production and characterization of improved liposomes containing radiographic contrast media.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2898%2900105-7

7 January 2021

The preparation and characterization of liposomes containing X-ray contrast agents

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2898%2900105-7

7 January 2021

The production and evaluation of contrast-carrying liposomes made with an automatic high-pressure system

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2898%2900105-7

7 January 2021

Preclinical characterization of iopromide-carrying liposomes

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2898%2900105-7

7 January 2021

Contrast material-carrying liposomes: biodistribution, clearance, and imaging characteristics

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2898%2900105-7

7 January 2021

Radio-opaque liposomes for the improved visualisation of focal liver disease by computerized tomography

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2898%2900105-7

7 January 2021

Evaluation of the dehydration-rehydration method for production of contrast-carrying liposomes

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2898%2900105-7

7 January 2021

Liposomes as carriers of iodolipid radiocontrast agents for CT scanning of the liver

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2898%2900105-7

7 January 2021

Enhancement of computed tomography liver contrast using iomeprol-containing liposomes and detection of small liver tumors in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2898%2900105-7

7 January 2021

A New Liposomal Contrast Medium for CT of the Liver

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2898%2900105-7

7 January 2021

Pharmacokinetics of iopromide liposomes in rabbits.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2898%2900105-7

7 January 2021

Liver contrast enhancement in primates using iopromide liposomes.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2898%2900105-7

7 January 2021

Iopromide-carrying liposomes as a contrast agent for the liver.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2898%2900105-7

7 January 2021

Biodistribution and computed tomography blood-pool imaging properties of polyethylene glycol-coated iopromide-carrying liposomes.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2898%2900105-7

7 January 2021

PEG-coated lipid vesicles with encapsulated Technetium-99m as blood pool agents for nuclear medicine

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2898%2900105-7

7 January 2021

Computed tomography of experimental liver abscesses using a new liposomal contrast agent

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2898%2900105-7

7 January 2021

Lung specific stealth liposomes: stability, biodistribution and toxicity of liposomal antitubercular drugs in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2898%2900105-7

7 January 2021

Preclinical evaluation of an iodinated particulate contrast agent for use during angiography: work in progress

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2898%2900105-7

7 January 2021

AUR Memorial Award 1990. The physiologic basis of the radiodense renal medulla after the administration of blood pool contrast agent PFOB.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2898%2900105-7

7 January 2021

Blood-Pool Contrast Media Are the Ideal Agents for Computed Tomography

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2898%2900105-7

7 January 2021

Blood pool radiopaque polymers. Design considerations.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2898%2900105-7

7 January 2021

Blood-Pool X-Ray Contrast Agents: Evaluation of a New Iodinated Polymer

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2898%2900105-7

7 January 2021

Iodinated Polymer as Blood-Pool Contrast Agent: Computed Tomography Evaluation in Rabbits

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2898%2900105-7

7 January 2021

Iodinated polymers. Pharmacokinetics of blood-pool imaging products

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2898%2900105-7

7 January 2021

10.1016/S0169-409X(98)00105-7

Identifiers

DOI

1 reference

23 September 2017

1 reference